Arrow Research search

Author name cluster

Rachael I. Scahill

Possible papers associated with this exact author name in Arrow. This page groups case-insensitive exact name matches and is not a full identity disambiguation profile.

13 papers
1 author row

Possible papers

13

YNICL Journal 2022 Journal Article

Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease

  • Paul Zeun
  • Peter McColgan
  • Thijs Dhollander
  • Sarah Gregory
  • Eileanoir B. Johnson
  • Marina Papoutsi
  • Akshay Nair
  • Rachael I. Scahill

OBJECTIVES: To investigate the timeframe prior to symptom onset when cortico-basal ganglia white matter (white matter) loss begins in premanifest Huntington's disease (preHD), and which striatal and thalamic sub-region white matter tracts are most vulnerable. METHODS: We performed fixel-based analysis, which allows resolution of crossing white matter fibres at the voxel level, on diffusion tractography derived white matter tracts of striatal and thalamic sub-regions in two independent cohorts; TrackON-HD, which included 72 preHD (approx. 11 years before disease onset) and 85 controls imaged at three time points over two years; and the HD young adult study (HD-YAS), which included 54 preHD (approx. 25 years before disease onset) and 53 controls, imaged at one time point. Group differences in fibre density and cross section (FDC) were investigated. RESULTS: We found no significant group differences in cortico-basal ganglia sub-region FDC in preHD gene carriers 25 years before onset. In gene carriers 11 years before onset, there were reductions in striatal (limbic and caudal motor) and thalamic (premotor, motor and sensory) FDC at baseline, with no significant change over 2 years. Caudal motor-striatal, pre-motor-thalamic, and primary motor-thalamic FDC at baseline, showed significant correlations with the Unified Huntington's disease rating scale (UHDRS) total motor score (TMS). Limbic cortico-striatal FDC and apathy were also significantly correlated. CONCLUSIONS: Our findings suggest that limbic and motor white matter tracts to the striatum and thalamus are most susceptible to early degeneration in HD but that approximately 25 years from onset, these tracts appear preserved. These findings may have importance in determining the optimum time to initiate future disease modifying therapies in HD.

YNICL Journal 2018 Journal Article

Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study

  • Verena Baake
  • Emma M. Coppen
  • Erik van Duijn
  • Eve M. Dumas
  • Simon J.A. van den Bogaard
  • Rachael I. Scahill
  • Hans Johnson
  • Blair Leavitt

Background: Huntington's disease (HD) is characterized by motor and behavioral symptoms, and cognitive decline. HD gene carriers and their caregivers report the behavioral and cognitive symptoms as the most burdensome. Apathy is the most common behavioral symptom of HD and is related to clinical measures of disease progression, like functional capacity. However, it is unknown whether apathy is directly related to the neurodegenerative processes in HD. Objective: The aim is to investigate whether an association between atrophy of subcortical structures and apathy is present in HD, at baseline and after 2 years follow-up. Method: Volumes of 7 subcortical structures were measured using structural T1 MRI in 171 HD gene carriers of the TRACK-HD study and apathy was assessed with the Problem Behaviors Assessment-Short, at baseline and follow-up visit. At baseline, logistic regression was used to evaluate whether volumes of subcortical brain structures were associated with the presence of apathy. Linear regression was used to assess whether subcortical atrophy was associated with the degree of apathy at baseline and with an increase in severity of apathy over time. Results: At baseline, smaller volume of the thalamus showed a higher probability of the presence of apathy in HD gene carriers, but none of the subcortical structures was associated with the degree of apathy. Over time, no association between atrophy of any subcortical structures and change in degree of apathy was found. Conclusion: The presence of apathy is associated with atrophy of the thalamus in HD, suggesting that apathy has an underlying neural cause and might explain the high incidence of apathy in HD. However, no association was found between atrophy of these subcortical structures and increase in severity of apathy over a 2-year time period.

YNICL Journal 2018 Journal Article

Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease

  • Lora Minkova
  • Sarah Gregory
  • Rachael I. Scahill
  • Ahmed Abdulkadir
  • Christoph P. Kaller
  • Jessica Peter
  • Jeffrey D. Long
  • Julie C. Stout

Huntington's disease (HD) is a progressive neurodegenerative disorder that can be genetically confirmed with certainty decades before clinical onset. This allows the investigation of functional and structural changes in HD many years prior to disease onset, which may reveal important mechanistic insights into brain function, structure and organization in general. While regional atrophy is present at early stages of HD, it is still unclear if both hemispheres are equally affected by neurodegeneration and how the extent of asymmetry affects domain-specific functional decline. Here, we used whole-brain voxel-based analysis to investigate cross-sectional and longitudinal hemispheric asymmetries in grey matter (GM) volume in 56 manifest HD (mHD), 83 pre-manifest HD (preHD), and 80 healthy controls (HC). Furthermore, a regression analysis was used to assess the relationship between neuroanatomical asymmetries and decline in motor and cognitive measures across the disease spectrum. The cross-sectional analysis showed striatal leftward-biased GM atrophy in mHD, but not in preHD, relative to HC. Longitudinally, no net 36-month change in GM asymmetries was found in any of the groups. In the regression analysis, HD-related decline in quantitative-motor (Q-Motor) performance was linked to lower GM volume in the left superior parietal cortex. These findings suggest a stronger disease effect targeting the left hemisphere, especially in those with declining motor performance. This effect did not change over a period of three years and may indicate a compensatory role of the right hemisphere in line with recent functional imaging studies.

YNIMG Journal 2014 Journal Article

Correction of inter-scanner and within-subject variance in structural MRI based automated diagnosing

  • Daniel Kostro
  • Ahmed Abdulkadir
  • Alexandra Durr
  • Raymund Roos
  • Blair R. Leavitt
  • Hans Johnson
  • David Cash
  • Sarah J. Tabrizi

Automated analysis of structural magnetic resonance images is a promising way to improve early detection of neurodegenerative brain diseases. Clinical applications of such methods involve multiple scanners with potentially different hardware and/or acquisition sequences and demographically heterogeneous groups. To improve classification performance, we propose to correct effects of subject-specific covariates (such as age, total intracranial volume, and sex) as well as effects of scanner by using a non-linear Gaussian process model. To test the efficacy of the correction, we performed classification of carriers of the genetic mutation leading to Huntington's disease (HD) versus healthy controls. Half of the HD carriers were free of typical HD symptoms and had an estimated 5 to 20years before onset of clinical symptoms, thus providing a model for preclinical diagnosis of a neurodegenerative disease. Structural magnetic resonance brain images were acquired at four sites with pairs of sites which had the identical scanner type, equipment, and acquisition parameters. For automatic classification, we used spatially normalized probabilistic maps of gray matter, then removed confounding effects by Gaussian process regression, and then performed classification with a support vector machine. Voxel-based morphometry of gray matter maps showed disease effects that were spatially wider spread than effects of scanner, but no significant interactions between scanner and disease were found. A model trained with data from a single scanner generalized well to data from a different scanner. When confounding diagnostics groups and scanner during training, e. g. by using controls from one scanner and gene carriers from another, classification accuracy dropped significantly in many cases. By regressing out confounds with Gaussian process regression, the performance levels were comparable to those obtained in scenarios without confound. We conclude that models trained on data acquired with a single scanner generalized well to data acquired with a different same-generation scanner even when the vendor differed. When confounding grouping and scanner during training is unavoidable to gather training data, regressing out inter-scanner and between-subject variability can reduce the loss in accuracy due to the confound.

YNICL Journal 2013 Journal Article

Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study

  • Nicola Z. Hobbs
  • James H. Cole
  • Ruth E. Farmer
  • Elin M. Rees
  • Helen E. Crawford
  • Ian B. Malone
  • Raymund A.C. Roos
  • Reiner Sprengelmeyer

BACKGROUND: Macro- and micro-structural neuroimaging measures provide valuable information on the pathophysiology of Huntington's disease (HD) and are proposed as biomarkers. Despite theoretical advantages of microstructural measures in terms of sensitivity to pathology, there is little evidence directly comparing the two. METHODS: 40 controls and 61 early HD subjects underwent 3 T MRI (T1- and diffusion-weighted), as part of the PADDINGTON study. Macrostructural volumetrics were obtained for the whole brain, caudate, putamen, corpus callosum (CC) and ventricles. Microstructural diffusion metrics of fractional anisotropy (FA), mean-, radial- and axial-diffusivity (MD, RD, AD) were computed for white matter (WM), CC, caudate and putamen. Group differences were examined adjusting for age, gender and site. A formal comparison of effect sizes determined which modality and metrics provided a statistically significant advantage over others. RESULTS: Macrostructural measures showed decreased regional and global volume in HD (p < 0.001); except the ventricles which were enlarged (p < 0.01). In HD, FA was increased in the deep grey-matter structures (p < 0.001), and decreased in the WM (CC, p = 0.035; WM, p = 0.053); diffusivity metrics (MD, RD, AD) were increased for all brain regions (p < 0.001). The largest effect sizes were for putamen volume, caudate volume and putamen diffusivity (AD, RD and MD); each was significantly larger than those for all other metrics (p < 0.05). CONCLUSION: The highest performing macro- and micro-structural metrics had similar sensitivity to HD pathology quantified via effect sizes. Region-of-interest may be more important than imaging modality, with deep grey-matter regions outperforming the CC and global measures, for both volume and diffusivity. FA appears to be relatively insensitive to disease effects.

YNIMG Journal 2012 Journal Article

An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease

  • Hubert M. Fonteijn
  • Marc Modat
  • Matthew J. Clarkson
  • Josephine Barnes
  • Manja Lehmann
  • Nicola Z. Hobbs
  • Rachael I. Scahill
  • Sarah J. Tabrizi

Understanding the progression of neurological diseases is vital for accurate and early diagnosis and treatment planning. We introduce a new characterization of disease progression, which describes the disease as a series of events, each comprising a significant change in patient state. We provide novel algorithms to learn the event ordering from heterogeneous measurements over a whole patient cohort and demonstrate using combined imaging and clinical data from familial Alzheimer's and Huntington's disease cohorts. Results provide new detail in the progression pattern of these diseases, while confirming known features, and give unique insight into the variability of progression over the cohort. The key advantage of the new model and algorithms over previous progression models is that they do not require a priori division of the patients into clinical stages. The model and its formulation extend naturally to a wide range of other diseases and developmental processes and accommodate cross-sectional and longitudinal input data.

YNIMG Journal 2009 Journal Article

Automated quantification of caudate atrophy by local registration of serial MRI: Evaluation and application in Huntington's disease

  • Nicola Z. Hobbs
  • Susie M.D. Henley
  • Edward J. Wild
  • Kelvin K. Leung
  • Chris Frost
  • Roger A. Barker
  • Rachael I. Scahill
  • Josephine Barnes

Objective: Caudate atrophy rate measured from serial MRI is proposed as a biomarker of HD progression that may be of use in assessing putative disease-modifying agents. Manual measurement techniques are the most widely applied but are time-consuming. We describe and evaluate an automated technique based on a local registration and boundary shift integral (BSI) approach at the caudate–CSF and caudate–white matter boundaries; caudate boundary shift integral (CBSI). Methods: Two-year caudate volume change was measured in controls, premanifest HD and early HD using the CBSI and compared with a detailed manual measure in terms of 1) raw caudate volume change, 2) group differentiation, 3) associations with clinical variables and 4) rater requirements. CBSI additivity was assessed by comparing measurements over a single scan pair (baseline→2 years), with the sum of measurements from two scan pairs (baseline→1 year→2 years). Results: Techniques produced comparable caudate volume change measurements, although CBSI under-reported by 0. 04 ml relative to manual. Both techniques distinguished controls, premanifest and early HD with a stepwise increase in rates across groups. Higher rates (CBSI and manual) were associated with increased proximity to estimated disease onset but not clinical change scores. CBSI reduced rater requirements by 2/3 (2 h per subject) relative to manual for this three time-point investigation. CBSI measurements over one scan pair showed good agreement with the sum of measurements from two scan pairs. Conclusions: CBSI results were comparable to a manual measure but with reduced rater requirements. CBSI may be of use in large-scale studies of HD.

YNIMG Journal 2008 Journal Article

Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images

  • Oscar Camara
  • Julia A. Schnabel
  • Gerard R. Ridgway
  • William R. Crum
  • Abdel Douiri
  • Rachael I. Scahill
  • Derek L.G. Hill
  • Nick C. Fox

The evaluation of atrophy quantification methods based on magnetic resonance imaging have been usually hindered by the lack of realistic gold standard data against which to judge these methods or to help refine them. Recently [Camara, O. , Schweiger, M. , Scahill, R. , Crum, W. , Sneller, B. , Schnabel, J. , Ridgway, G. , Cash, D. , Hill, D. , Fox, N. , 2006. Phenomenological model of diffuse global and regional atrophy using finite-element methods. IEEE Trans. Med. l Imaging 25, 1417–1430], we presented a technique in which atrophy is realistically simulated in different tissue compartments or neuroanatomical structures with a phenomenological model. In this study, we have generated a cohort of realistic simulated Alzheimer's disease (AD) images with known amounts of atrophy, mimicking a set of 19 real controls and 27 probable AD subjects, with an improved version of our atrophy simulation methodology. This database was then used to assess the accuracy of several well-known computational anatomy methods which provide global (BSI and SIENA) or local (Jacobian integration) estimates of longitudinal atrophy in brain structures using MR images. SIENA and BSI results correlated very well with gold standard data (Pearson coefficient of 0. 962 and 0. 969 respectively), achieving small mean absolute differences with respect to the gold standard (percentage change from baseline volume): BSI of 0. 23%±0. 26%; SIENA of 0. 22%±0. 28%. Jacobian integration was guided by both fluid and FFD-based registration techniques and resulting deformation fields and associated Jacobians were compared, region by region, with gold standard ones. The FFD-based technique outperformed the fluid one in all evaluated structures (mean absolute differences from the gold standard in percentage change from baseline volume): whole brain, FFD=0. 31%, fluid=0. 58%; lateral ventricles, FFD=0. 79%; fluid=1. 45%; left hippocampus, FFD=0. 82%; fluid=1. 42%; right hippocampus, FFD=0. 95%; fluid=1. 62%. The largest errors for both local techniques occurred in the sulcal CSF (FFD=2. 27%; fluid=3. 55%) regions. For large structures such as the whole brain, these mean absolute differences, relative to the applied atrophy, represented similar percentages for the BSI, SIENA and FFD techniques (controls/patients): BSI, 51. 99%/16. 36%; SIENA, 62. 34%/21. 59%; FFD, 41. 02%/24. 95%. For small structures such as the hippocampi, these percentages were larger, especially for controls where errors were approximately equal to the small applied changes (controls/patients): FFD, 92. 82%/43. 61%. However, these apparently large relative errors have not prevented the global or hippocampal measures from finding significant group separation in our study. The evaluation framework presented here will help in quantifying whether the accuracy of future methodological developments is sufficient for analysing change in smaller or less atrophied local brain regions. Results obtained in our experiments with realistic simulated data confirm previously published estimates of accuracy for both evaluated global techniques. Regarding Jacobian Integration methods, the FFD-based one demonstrated promising results and potential for being used in clinical studies alongside (or in place of) the more common global methods. The generated gold standard data has also allowed us to identify some stages and sets of parameters in the evaluated techniques – the brain extraction step in the global techniques and the number of multi-resolution levels and the stopping criteria in the registration-based methods – that are critical for their accuracy.

YNIMG Journal 2008 Journal Article

Ten simple rules for reporting voxel-based morphometry studies

  • Gerard R. Ridgway
  • Susie M.D. Henley
  • Jonathan D. Rohrer
  • Rachael I. Scahill
  • Jason D. Warren
  • Nick C. Fox

Voxel-based morphometry [Ashburner, J. and Friston, K. J. , 2000. Voxel-based morphometry—the methods. NeuroImage 11(6 Pt 1), 805–821] is a commonly used tool for studying patterns of brain change in development or disease and neuroanatomical correlates of subject characteristics. In performing a VBM study, many methodological options are available; if the study is to be easily interpretable and repeatable, the processing steps and decisions must be clearly described. Similarly, unusual methods and parameter choices should be justified in order to aid readers in judging the importance of such options or in comparing the work with other studies. This editorial suggests core principles that should be followed and information that should be included when reporting a VBM study in order to make it transparent, replicable and useful.

YNIMG Journal 2004 Journal Article

Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates

  • Josephine Barnes
  • Rachael I. Scahill
  • Richard G. Boyes
  • Chris Frost
  • Emma B. Lewis
  • Charlotte L. Rossor
  • Martin N. Rossor
  • Nick C. Fox

Manual segmentation of the hippocampus is the gold standard in volumetric hippocampal magnetic resonance imaging (MRI) analysis; however, this is difficult to achieve reproducibly. This study explores whether application of local registration and calculation of the hippocampal boundary shift integral (HBSI) can reduce random variation compared with manual measures. Hippocampi were outlined on the baseline and registered-repeat MRIs of 32 clinically diagnosed Alzheimer's disease (AD) patients and 47 matched controls (37–86 years) with a wide range of scanning intervals (175–1173 days). The scans were globally registered using 9 degrees of freedom and subsequently locally registered using 6 degrees of freedom and HBSI was then calculated automatically. HBSI significantly reduced the mean rate (P < 0. 01) and variation in controls (P < 0. 001) and increased group separation between AD cases and controls. When comparing HBSI atrophy rates with manually derived atrophy rates at 90% sensitivity, specificities were 98% and 81%, respectively. From logistic regression models, a 1% increase in HBSI atrophy rates was associated with an 11-fold (CI 3, 36) increase in the odds of a diagnosis of AD. For manually derived atrophy rates, the equivalent odds ratio was 3 (CI 2, 4). We conclude that HBSI-derived atrophy rates reduce operator time and error, and are at least as effective as the manual equivalent as a diagnostic marker and are a potential marker of progression in longitudinal studies and trials.

YNIMG Journal 2002 Journal Article

Automatic Differentiation of Anatomical Patterns in the Human Brain: Validation with Studies of Degenerative Dementias

  • Catriona D. Good
  • Rachael I. Scahill
  • Nick C. Fox
  • John Ashburner
  • Karl J. Friston
  • Dennis Chan
  • William R. Crum
  • Martin N. Rossor

We compared voxel-based morphometry (VBM) with independent accurate region-of-interest (ROI) measurements of temporal lobe structures in order to validate the usefulness of this fully automated and unbiased technique in Alzheimer's disease (AD) and semantic dementia (SD). In AD, ROI analyses appear more sensitive to volume loss in the amygdalae, whereas VBM analyses appear more sensitive to right middle temporal gyrus and regional hippocampal volume loss. In SD, ROI analyses appear more sensitive to left middle and inferior temporal gyrus volume loss, whereas VBM appears more sensitive to regional hippocampal volume loss. In addition the significance of volume reductions was generally less in VBM owing to more stringent corrections for multiple comparisons. In conclusion, the automated technique detects a general trend of atrophy similar to that of expertly labeled ROI measurements in AD and SD, although there are discrepancies in the ranking of severity and in the significance of volume reductions that are more marked in AD.

YNIMG Journal 2001 Journal Article

Automated Hippocampal Segmentation by Regional Fluid Registration of Serial MRI: Validation and Application in Alzheimer's Disease

  • William R. Crum
  • Rachael I. Scahill
  • Nick C. Fox

The application of voxel-level three-dimensional registration to serial magnetic resonance imaging (MRI) is described. This fluid registration determines deformation fields modeling brain change, which are consistent with a model describing a viscous fluid. The objective was to validate the measurement of hippocampal volumetric change by fluid registration in Alzheimer's disease (AD) against current methodologies. The hippocampus was chosen for this study because it is difficult to measure reproducibly by manual segmentation and is widely studied; however, the technique is applicable to any structure which can be delineated on a scan. First, suitable values for the viscosity-body-force-ratio, α (0. 01), and the number of iterations (300), were established and the convergence, repeatability, linearity, and accuracy investigated and compared with expert manual segmentation. A simple model of hippocampal atrophy was used to compare simulated volumetric change against that obtained by fluid registration. Finally the serial segmentation was compared with the current gold standard technique—expert human labeling with a volume repeatability of ∼4%—in 27 subjects (15 normal controls, 12 clinically diagnosed with Alzheimer's disease). The scan-rescan volumetric consistency of serial segmentation by fluid-registration was shown to be superior to human serial segmentors (∼2%). The mean absolute volume difference between fluid and manual segmentation was 0. 7%. Fluid registration has potential importance for tracking longitudinal structural changes in brain particularly in the context of the clinical trial where large numbers of subjects may have multiple MR scans.

v2026.09.13